Tyrosine kinase inhibitor (TKI) therapy for newly-diagnosed patients with chronic myeloid leukemia: focusing on TKI discontinuation due to adverse events - is better always good?
| Image |  |
|---|---|
| Description | scientific article published on 6 June 2017 |
| Author/s |
author: Ahmet Emre Eskazan |
| Publication date | June 6, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |